Skip to main content
Log in

Growth hormone receptor gene mutations in two Italian patients with Laron Syndrome

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Laron Syndrome (LS) represents a condition characterized by GH insensitivity caused by molecular defects in the GH receptor (GHR) gene or in the post-receptor signalling pathway. We report the molecular characterization of two unrelated Italian girls from Sicily diagnosed with LS. The DNA sequencing of the GHR gene revealed the presence of different nonsense mutations, occurring in the same background haplotype. The molecular defects occurred in the extracellular domain of the GHR leading to a premature termination signal and to a truncated non-functional receptor. In one patient, a homozygous G to T transversion, in exon 6, led to the mutation GAA to TAA at codon 180 (E180X), while in the second patient a homozygous C to T transition in exon 7 was detected, causing the CGA to TAA substitution at codon 217 (R217X). Both probands presented the polymorphisms Gly168Gly and Ile544Leu in a homozygous state in exons 6 and 10, respectively. The E180X represents a novel defect of the GHR gene, while the R217X mutation has been previously reported in several patients from different ethnic backgrounds but all from countries located in the Mediterranean and Middle Eastern region.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Isaksson OGP, Eden S, Jansson J-O. Mode of action of pituitary growth hormone on target cells. Annu Rev Physiol 1985, 47: 483–99.

    Article  PubMed  CAS  Google Scholar 

  2. Wells JA. Binding in the growth hormone receptor complex. Proc Natl Acad Sci USA 1996, 93: 1–6.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  3. Leung DW, Spencer SA, Cachianes G, et al. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987, 330: 537–43.

    Article  PubMed  CAS  Google Scholar 

  4. Godowski PJ, Leung DW, Meacham LR, et al. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA 1989, 86: 8083–7.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  5. Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone: a new inborn error of metabolism? Isr J Med Sci 1966, 2: 152–5.

    PubMed  CAS  Google Scholar 

  6. Laron Z. Growth hormone insensitivity (Laron syndrome). Rev Endocr Metab Disord 2002, 3: 347–55

    Article  PubMed  CAS  Google Scholar 

  7. Laron Z, Pertzelan A, Karp M, Kowadlo-Silbergeld A, Daughaday WH. Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth response. J Clin Endocrinol Metab 1971, 33: 332–42.

    Article  PubMed  CAS  Google Scholar 

  8. Savage MO, Blair JC, Jorge AJ, Street ME, Ranke MB, Camacho-Hübner C. IGFs and IGFBPs in GH insensitivity. Endocr Dev 2005, 9: 100–6.

    Article  PubMed  CAS  Google Scholar 

  9. Woods KA, Dastot F, Preece MA, et al. Phenotype: genotype relationships in growth hormone insensitivity syndrome. J Clin Endocrinol Metab 1997, 82: 3529–35.

    Article  PubMed  CAS  Google Scholar 

  10. Amselem S, Duquesnoy P, Duriez B, et al. Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome. Hum Mol Genet 1993, 2: 355–9.

    Article  PubMed  CAS  Google Scholar 

  11. Berg MA, Argente J, Chernausek S, et al. Diverse growth hormone receptor mutations in Laron syndrome. Am J Hum Genet 1993, 52: 998–1005.

    PubMed Central  PubMed  CAS  Google Scholar 

  12. Krawczak M, Ball EV, Fenton I, et al. Human gene mutation database: a biomedical information and research resource. Hum Mutat 2000, 15: 45–51.

    Article  PubMed  CAS  Google Scholar 

  13. Laron Z. Laron Syndrome (Primary Growth Hormone Resistance or Insensitivity): The Personal Experience 1958–2003. J Clin Endocrinol Metab 2004, 89: 1031–44.

    Article  PubMed  CAS  Google Scholar 

  14. Shevah O, Rubinstein M, Laron Z. Molecular defects of the growth hormone receptor gene, including a new mutation, in Laron syndrome patients in Israel: relationship between defects and ethnic groups. Isr Med Assoc J 2004, 6: 630–3.

    PubMed  CAS  Google Scholar 

  15. Rosenfeld RG, Buckway C, Selva K, Pratt KL, Guevara-Aguirre J. Insulin-like growth factor (IGF) parameters and tools for efficacy: the IGF-I generation test in children. Horm Res 2004, 62 Suppl 1: 37–43.

    Article  PubMed  CAS  Google Scholar 

  16. Shevah O, Borrelli P, Rubinstein M, Laron Z. Identification of two novel mutations in the human growth hormone receptor gene. J Endocrinol Invest 2003, 26: 604–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Bona MD.

Additional information

First co-authorship.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fassone, L., Corneli, G., Bellone, S. et al. Growth hormone receptor gene mutations in two Italian patients with Laron Syndrome. J Endocrinol Invest 30, 417–420 (2007). https://doi.org/10.1007/BF03346320

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346320

Key-words

Navigation